510(k) device
Extracorporeal Shock Wave Lithotripter (U200)
Shenzhen Wikkon Precision Technologies Co., Ltd. · Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS, Class II) · First FDA decision Jun 18, 2025, newest Jun 18, 2025Kidney stones
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
300
Naming "Extracorporeal Shock Wave"
MAUDE reports
5
Brand "Extracorporeal Shock Wave", since 2015
PubMed studies
6,466
Mentioning "Extracorporeal Shock Wave"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Extracorporeal Shock Wave Lithotripter (U200)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K242922 · Decided Jun 18, 2025 · 267 days after receipt
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Extracorporeal Shock Wave Therapy (ESWT)Local determinationIn effectL38775Palmetto GBAUpdated Sep 6, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Extracorporeal Shock Wave", any status and sponsor, newest update first.
- FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb SpasticityCompleted
National Taiwan University HospitalAcademic, hospital or other
NCT06365476 · 40 participants · Start Apr 13, 2024 · Primary completion Jul 31, 2026
Device: focused extracorporeal shock wave therapy (ESWT) · For: Stroke; Spasticity, Muscle
Sites: Taipei, Taiwan
South Valley UniversityAcademic, hospital or other
NCT06159192 · 80 participants · Start Mar 1, 2024 · Primary completion Jun 20, 2024
Device: Low intensity extracorporeal shock wave · For: Shock Wave and Nitric Oxide
Sites: Luxor, Egypt
Sehat Medical ComplexAcademic, hospital or other
NCT07470190 · 60 participants · Start Feb 23, 2026 · Primary completion Nov 16, 2026
Device: ESWT · For: Supraspinatus Tendinitis
Sites: Lahore, Pakistan
297 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Extracorporeal Shock Wave", and for the whole product code for context.
This brand
5 reports: 3 malfunction, 1 injury, 1 death
Whole product code LNS
605 reports: 95 malfunction, 498 injury, 11 death
Newest reports for this brand
MW5187612 · Received May 4, 2026 · Event dated Jan 1, 2024
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Patient problem as coded: Unspecified Skin and Subcutaneous Tissue Problem
MW5165548 · Received Jan 31, 2025 · Event dated Jan 27, 2025
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Patient problem as coded: Insufficient Information
MW5164420 · Received Jan 7, 2025 · Event dated Dec 3, 2024
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Extracorporeal Shock Wave"[tiab]. The summary above synthesizes these.
- [Achilles tendinopathy].
Rueth MJ, Koehl P, Schuh A · MMW Fortschr Med · 2024Review
- [Extracorporeal shock wave therapy for Peyronie's disease].
Ochoa A, Guillot-Tantay C, Faix A, et al. · Prog Urol · 2020Systematic Review
- Steinstrasse following extracorporeal shock wave lithotripsy.
Garrido-Abad P, Rodriguez-Cabello MÁ, Platas-Sancho A · Arch Esp Urol · 2021
- Extracorporeal shock-wave lithotripsy.
Maher PO · Med J Aust · 1986Editorial
- Extracorporeal shock-wave lithotripsy.
Saltzman B · Compr Ther · 1990Review
- Extracorporeal Shock Wave Therapy Promotes Osteogenic Differentiation in a Rabbit Osteoporosis Model.
Li B, Wang R, Huang X, et al. · Front Endocrinol (Lausanne) · 2021Research Support, Non-U.S. Gov't
- Opinion: Application of extracorporeal shock wave therapy in nervous system diseases.
Jokinen LLJ, Wuerfel T, Schmitz C · Front Neurol · 2023
- Extracorporeal shock wave lithotripsy: the cornerstone of pancreatic endotherapy.
Bhandari S, Maydeo A · Gastrointest Endosc · 2016Editorial, Comment
- Effectiveness of extracorporeal shock wave lithotripsy in nephro-uretero-cystolithiasis.
Moreno-Alfonso JC, Moraleda de Heredia B, Molina Caballero A, et al. · An Pediatr (Engl Ed) · 2024Case Reports, Letter
- Extracorporeal Shock Wave Lithotripsy for Pancreaticolithiasis: Do It Now.
Jagtap N, Tandan M, Reddy DN · Clin Gastroenterol Hepatol · 2021Letter, Comment
- Spasticity Treatment Beyond Botulinum Toxins.
Li S, Winston P, Mas MF · Phys Med Rehabil Clin N Am · 2024Review, Research Support, Non-U.S. Gov't
- Extracorporeal shock wave lithotripsy.
Shagam JY · Radiol Technol · 2000Review
Other devices of this type
Also filed under product code LNS.
- Delta III LithotripterDornier Medtech America, Inc. · 510(k) 2020
- Break WaveSonomotion, Inc. · 510(k) 2026
- Tripter X-1 CompactDirex Systems Corp. · 510(k) 2004
- Delta III ProDornier Medtech America, Inc. · 510(k) 2023
- LM-9300 Plus LithotripterLite-Med, Inc. · 510(k) 2023
- Modulith SLX-F2Karl Storz Endoscopy America · 510(k) 2021
- Gemini XXP-HPDornier Medtech America · 510(k) 2015
- LM-9300 ELMA LithotripterLite-Med, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.